GeneDx’s ExomeDx and GenomeDx tests, now FDA Breakthrough Designated, offer comprehensive genomic analysis to improve diagnosis of rare and serious diseases.
Mimi C. Lee, MD, PhD
Advertisement
Mimi C. Lee, MD, PhD, Chief of Precision Genetic Medicine, GeneDx, San Francisco Bay Area.
Articles by Mimi C. Lee, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Meta-analysis finds vegetarian and vegan diets can support healthy growth in children
2
FDA approves gepotidacin as oral treatment for urogenital gonorrhea
3
Weekly review: Big week for pediatric FDA approvals
4
Mimi C. Lee, MD, PhD, breaks down GeneDx's ExomeDx and GenomeDx tests
5
